FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

 
Share
 

Manage episode 200758344 series 1452688
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

FDA medical oncologists discuss the agency’s March 2017 approval of niraparib for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.

Released May 18, 2017

130 episodes available. A new episode about every 37 days averaging 0 mins duration .